5Suppliers
4Customers
1Debt Items
20Related Chains

BioNTech SE Suppliers

TickerNameConfidenceEvidence
EVAX Evaxion A/S 72% Reciprocal relationship from EVAX graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from EVAX graph: drugs, has become intense. As a result, increasingly high barriers are being…
MGNX MacroGenics, Inc. 72% Reciprocal relationship from MGNX graph: n exclusive option to license worldwide rights to the research program, upon achievement of a pre-defined preclinical milestone. HIV DART Molecules We conduct…
MRVI Maravai LifeSciences Holdings, Inc. 72% Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MRVI g…
MTNB Matinas BioPharma Holdings, Inc. 72% Reciprocal relationship from MTNB graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from MTNB g…
SMMT Summit Therapeutics Inc. 72% Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT g…

BioNTech SE Customers

TickerNameConfidenceEvidence
EVAX Evaxion A/S 72% Reciprocal relationship from EVAX graph: ing income in the mid double-digit range. We have initiated a Phase 2 trial, hence this term is no longer relevant. Prior to any out-licensing commercializati…
MGNX MacroGenics, Inc. 72% Reciprocal relationship from MGNX graph: t and future product candidates. Most of the principal materials we use in our manufacturing operations are available from more than one source. However, we o…
MTNB Matinas BioPharma Holdings, Inc. 72% Reciprocal relationship from MTNB graph: contractors associated with Chemistry and Manufacturing Controls (CMC), pre-clinical and clinical activities and regulatory operations; ● expenses incurred un…
SMMT Summit Therapeutics Inc. 72% Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from SMMT g…

BioNTech SE Debt Obligations

InstrumentDescriptionConfidenceEvidence
BNTX-DEBT Debt stack $352.2M 90% Market cache reports total debt of $352.2M.

BioNTech SE Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for BioNTech SE.

BioNTech SE Ownership

HolderNameConfidenceEvidence
BNTX-OWNER-T-ROWE-PRICE-INVESTMENT-MANAGEME T. Rowe Price Investment Management, Inc. 90% 13F overlay lists T. Rowe Price Investment Management, Inc. as top holder; 274 tracked holders.

BioNTech SE Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNYNF Sanofi 100.00 2
PYXS Pyxis Oncology, Inc. 100.00 2
BORAY Bora Pharmaceuticals Co., Ltd. 100.00 2
SMMT Summit Therapeutics Inc. 100.00 2 ['customer', 'supplier']
MRK Merck & Co., Inc. 100.00 2
MRVI Maravai LifeSciences Holdings, Inc. 100.00 1 ['supplier']
AZN AstraZeneca PLC 100.00 2
ECO Okeanis Eco Tankers Corp. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
ARTV Artiva Biotherapeutics, Inc. 100.00 2
CMPX Compass Therapeutics, Inc. 100.00 2
CLLS Cellectis S.A. 100.00 2
EVAX Evaxion A/S 100.00 1 ['customer', 'supplier']
GILD Gilead Sciences, Inc. 100.00 2
GSK GSK plc 100.00 2
GNMSF Genmab A/S 100.00 2
INBX Inhibrx Biosciences, Inc. 100.00 2
INCY Incyte Corporation 100.00 2
CAH Cardinal Health, Inc. 100.00 2
MTNB Matinas BioPharma Holdings, Inc. 100.00 1 ['customer', 'supplier']